The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Laura C Coates, William Tillett, David Chandler, Philip S Helliwell, Eleanor Korendowych, Stuart Kyle, Iain B McInnes, Susan Oliver, Anthony Ormerod, Catherine Smith, Deborah Symmons, Nicola Waldron, Neil J McHugh, BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

Research output: Contribution to journalArticle

59 Citations (Scopus)
Original languageEnglish
Pages (from-to)1754-1757
Number of pages4
JournalRheumatology
Volume52
Issue number10
Early online date25 Jul 2013
DOIs
Publication statusPublished - Oct 2013

Keywords

  • algorithms
  • antirheumatic agents
  • arthritis, psoriatic
  • biological products
  • humans
  • treatment failure
  • tumor necrosis factor-alpha
  • biologics
  • treatment
  • management
  • guidelines
  • recommendations
  • anti-TNF therapies
  • psoriasis
  • enthesitis
  • dactylitis

Cite this

Coates, L. C., Tillett, W., Chandler, D., Helliwell, P. S., Korendowych, E., Kyle, S., ... BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR (2013). The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology, 52(10), 1754-1757. https://doi.org/10.1093/rheumatology/ket187

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. / Coates, Laura C; Tillett, William; Chandler, David; Helliwell, Philip S; Korendowych, Eleanor; Kyle, Stuart; McInnes, Iain B; Oliver, Susan; Ormerod, Anthony; Smith, Catherine; Symmons, Deborah; Waldron, Nicola; McHugh, Neil J; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR.

In: Rheumatology, Vol. 52, No. 10, 10.2013, p. 1754-1757.

Research output: Contribution to journalArticle

Coates, LC, Tillett, W, Chandler, D, Helliwell, PS, Korendowych, E, Kyle, S, McInnes, IB, Oliver, S, Ormerod, A, Smith, C, Symmons, D, Waldron, N, McHugh, NJ & BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR 2013, 'The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics', Rheumatology, vol. 52, no. 10, pp. 1754-1757. https://doi.org/10.1093/rheumatology/ket187
Coates LC, Tillett W, Chandler D, Helliwell PS, Korendowych E, Kyle S et al. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology. 2013 Oct;52(10):1754-1757. https://doi.org/10.1093/rheumatology/ket187
Coates, Laura C ; Tillett, William ; Chandler, David ; Helliwell, Philip S ; Korendowych, Eleanor ; Kyle, Stuart ; McInnes, Iain B ; Oliver, Susan ; Ormerod, Anthony ; Smith, Catherine ; Symmons, Deborah ; Waldron, Nicola ; McHugh, Neil J ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. / The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. In: Rheumatology. 2013 ; Vol. 52, No. 10. pp. 1754-1757.
@article{2b1b4386085e451baea76764bb42da0c,
title = "The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics",
keywords = "algorithms, antirheumatic agents, arthritis, psoriatic, biological products, humans, treatment failure, tumor necrosis factor-alpha, biologics, treatment, management, guidelines, recommendations, anti-TNF therapies, psoriasis, enthesitis, dactylitis",
author = "Coates, {Laura C} and William Tillett and David Chandler and Helliwell, {Philip S} and Eleanor Korendowych and Stuart Kyle and McInnes, {Iain B} and Susan Oliver and Anthony Ormerod and Catherine Smith and Deborah Symmons and Nicola Waldron and McHugh, {Neil J} and {BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR}",
year = "2013",
month = "10",
doi = "10.1093/rheumatology/ket187",
language = "English",
volume = "52",
pages = "1754--1757",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "OXFORD UNIV PRESS INC",
number = "10",

}

TY - JOUR

T1 - The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

AU - Coates, Laura C

AU - Tillett, William

AU - Chandler, David

AU - Helliwell, Philip S

AU - Korendowych, Eleanor

AU - Kyle, Stuart

AU - McInnes, Iain B

AU - Oliver, Susan

AU - Ormerod, Anthony

AU - Smith, Catherine

AU - Symmons, Deborah

AU - Waldron, Nicola

AU - McHugh, Neil J

AU - BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

PY - 2013/10

Y1 - 2013/10

KW - algorithms

KW - antirheumatic agents

KW - arthritis, psoriatic

KW - biological products

KW - humans

KW - treatment failure

KW - tumor necrosis factor-alpha

KW - biologics

KW - treatment

KW - management

KW - guidelines

KW - recommendations

KW - anti-TNF therapies

KW - psoriasis

KW - enthesitis

KW - dactylitis

U2 - 10.1093/rheumatology/ket187

DO - 10.1093/rheumatology/ket187

M3 - Article

C2 - 23887065

VL - 52

SP - 1754

EP - 1757

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 10

ER -